Identification of the Acyltransferase that Octanoylates Ghrelin, an Appetite-Stimulating Peptide Hormone  by Yang, Jing et al.
Identification of the Acyltransferase
that Octanoylates Ghrelin,
an Appetite-Stimulating Peptide Hormone
Jing Yang,1 Michael S. Brown,1,* Guosheng Liang,1 Nick V. Grishin,2,3 and Joseph L. Goldstein1,*
1Department of Molecular Genetics
2Department of Biochemistry
3Howard Hughes Medical Institute
University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
*Correspondence: mike.brown@utsouthwestern.edu (M.S.B.), joe.goldstein@utsouthwestern.edu (J.L.G.)
DOI 10.1016/j.cell.2008.01.017SUMMARY
Ghrelin is a 28 amino acid, appetite-stimulating pep-
tide hormone secreted by the food-deprived stom-
ach. Serine-3 of ghrelin is acylated with an eight-
carbon fatty acid, octanoate, which is required for
its endocrine actions. Here, we identify GOAT (Ghre-
linO-Acyltransferase), a polytopic membrane-bound
enzyme that attaches octanoate to serine-3 of ghre-
lin. Analysis of the mouse genome revealed that
GOAT belongs to a family of 16 hydrophobic mem-
brane-bound acyltransferases that includes Porcu-
pine, which attaches long-chain fatty acids to Wnt
proteins. GOAT is the only member of this family
that octanoylates ghrelin when coexpressed in
cultured endocrine cell lines with prepro-ghrelin.
GOAT activity requires catalytic asparagine and his-
tidine residues that are conserved in this family. Con-
sistent with its function, GOAT mRNA is largely
restricted to stomach and intestine, the major ghre-
lin-secreting tissues. Identification of GOAT will facil-
itate the search for inhibitors that reduce appetite
and diminish obesity in humans.
INTRODUCTION
The appetite-stimulating peptide hormone, ghrelin, is the only
protein in animals that is known to be modified by O-acylation
with octanoate, an eight-carbon fatty acid. Octanoylation is re-
quired for the endocrine actions of ghrelin, but the enzyme that
catalyzes this modification has not yet been identified (Kojima
and Kangawa, 2005).
The discovery of ghrelin was reported in 1999 by Kojima et al.
(1999), who were searching for a ligand for an orphan G protein
coupled receptor (GHS-R1a) that stimulates the secretion of
growth hormone in the pituitary gland. The ligand was purified
from rat stomach, and it was shown to stimulate the release of
growth hormone from cultured pituitary cells. Kojima, et al.
(1999) determined that the 28 amino acid ghrelin is derived pro-teolytically from a precursor of 117 amino acids. Analysis by
mass spectroscopy revealed that serine-3 of ghrelin is modified
by O-acylation with an octanoyl group, which is required for
growth hormone releasing activity. Serine-3 is conserved in
mammals, birds, and fish. In ghrelin of the bullfrog, serine-3 is re-
placed by threonine, but this residue is also octanoylated (Kojima
and Kangawa, 2005). Thus, O-octanoylation of ghrelin has been
conserved in vertebrates over millions of years of evolution. Like-
wise, the GHS-R1a receptor for octanoylated ghrelin has also
been highly conserved in vertebrates as far back as zebrafish
(NCBI database, XP_001340408).
Interest in ghrelin rose dramatically when it was demonstrated
that ghrelin concentrations in human plasma rise immediately
before mealtimes (Cummings et al., 2001; Cummings, 2006).
How much of this ghrelin surge represents the acylated active
form is unknown. Infusion of acylated ghrelin into the cerebral
ventricles of rats markedly enhances food intake apparently
through actions on the hypothalamus (Kamegai et al., 2001).
Peripheral administration of ghrelin to humans stimulates food
intake (Wren et al., 2001; Small and Bloom, 2004). Elimination
of ghrelin or its receptor in mice through knockout technology
caused a modest but significant reduction in obesity when the
mice were presented with high fat diets (Wortley et al., 2005; Zig-
man et al., 2005). These findings aroused interest in ghrelin inhib-
itors as potential preventatives for obesity in humans.
One way to inhibit the action of ghrelin would be to block the
enzyme that attaches octanoate. An inhibitor should be quite
specific since no other protein is known to be octanoylated.
Thus far, however, the octanoylating enzyme has escaped iden-
tification. In the current studies, we have identified the ghrelin-
acylating enzyme by taking advantage of the bioinformatic
work of Hofmann (2000), who delineated a family of acyltrans-
ferases that catalyze O-acylation reactions. The initial insight
came from studies on the Drosophila wingless gene and its
mammalian homolog, Wnt. Genetic studies in Drosophila had
earlier demonstrated that Wingless activity required the action
of another gene porcupine (Kadowaki et al., 1996). Hofmann ob-
served that the amino acid sequence of Porcupine contains
a conserved region that is found in a variety of membrane-bound
hydrophobic enzymes that transfer long-chain fatty acids to
membrane-associated hydroxyl acceptors. Hofmann namedCell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc. 387
Figure 1. Amino Acid Sequence and Domain Structure of GOAT
(A) Alignment of themost highly conserved region of all 16MBOATs in themouse genome. Amino acid residues conserved inmore than 50%of the sequences are
shaded. Asterisks (*) denote the putative catalytic asparagine and histidine residues (Hofmann, 2000). In the case of MBOATs with different isoforms (MBOAT1,
MBOAT2, and PORC), for simplicity the numbering refers to isoform-a. Substrates for MBOATs are shown in parentheses.
(B) Hydropathy plot of mouse GOAT. The residue-specific hydropathy index was calculated over a window of 18 residues with software from DNASTAR. The
predicted 8 transmembrane helices are numbered. Bar denotes the region of GOAT that contains the two catalytic residues as denoted in (A).388 Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc.
this family MBOATs for Membrane-Bound O-Acyltransferases.
Other examples include acyl-CoA:cholesterol acyltransferases
(ACATs), which attach fatty acids to the hydroxyl group of cho-
lesterol and diacylglycerol acyltransferase-1 (DGAT1), which
acylates the hydroxyl group of diacylglycerol.
Subsequent studies showed that Porcupine is required for the
attachment of long-chain fatty acids to serine and cysteine res-
idues inWnt (Willert et al., 2003; Takada et al., 2006). Like Porcu-
pine, all other MBOATs are believed to transfer only long-chain
fatty acids of 16–18 carbons. Here, we show that the mouse
genome encodes 16 MBOATs produced by 11 genes and dem-
onstrate that one of these MBOATs catalyzes the octanoylation
of ghrelin when it is expressed together with prepro-ghrelin in




in the Mouse Genome
Figure 1A shows the conserved sequences in the putative cata-
lytic domains of mammalian proteins that belong to the MBOAT
family. These 11 catalytic domains are found in 16 MBOAT pro-
teins since two of the encoding genes give rise to two isoforms
and one gives rise to four isoforms as a result of alternative splic-
ing. We identified these sequences through a search of genomic
databases (see Experimental Procedures). The criteria for inclu-
sion were based on the original work of Hofmann (2000), who
identified this family. The asparagine and histidine residues
that are thought to participate in catalysis are indicated by aster-
isks. All of these enzymes are postulated to transfer fatty acyl
groups to hydroxyl or sulfhydryl groups, forming ester or thio-
ester bonds. Among the known substrates are lipids such as
cholesterol and diacylglycerol. At least one protein, Wnt, is
thought to be a substrate by virtue of a serine that is acylated
(Takada et al., 2006). As described below, MBOAT4 is now
shown to mediate the octanoylation of ghrelin, and hence it is
designated GOAT. The substrates for seven of the putative
MBOATs (MBOAT1-a/b, MBOAT2-a/b, MBOAT5, LRC4, and
GUP1) remain unknown.
Figure 1B shows a hydropathy plot of mouse GOAT. The se-
quence suggests eight transmembrane segments, a finding in
keeping with the sequences of other MBOATs, all of which
havemultiple membrane-spanning helices. The GOAT sequence
is highly conserved inmammalian and avian species, and a close
relative is found in zebrafish (Figure 1C). The putative catalytic
asparagine and histidine residues are conserved throughout.
Proteolytic Processing of Prepro-Ghrelin in INS-1 Cells
As a first step in identifying the enzyme that octanoylates ghrelin,
we sought to identify cultured cells that process pro-ghrelin to
ghrelin. For this purpose we produced prepro-ghrelin in a variety
of cultured cell lines through cDNA transfection. As shown in
Figure 2A, prepro-ghrelin contains 117 amino acids (Kojimaand Kangawa, 2005). Cleavage of the 23 amino acid signal se-
quence yields pro-ghrelin, which has glycine as its N-terminal
residue, hereafter designated residue 1. The C terminus of ma-
ture ghrelin is generated by prohormone convertase 1/3, which
cleaves after arginine-28 of pro-ghrelin, generating the mature
28 amino acid peptide (Zhu et al., 2006).
After transfection, cell extracts were subjected to SDS-PAGE
and immunoblotted with a polyclonal antibody that we raised
against mouse ghrelin. All of the transfected cells produced an
immunoreactive peptide with an apparent molecular mass of
12 kDa that corresponds to pro-ghrelin with the signal sequence
removed (Figure 2B). Three endocrine cell lines—mouse pituitary
AtT-20 cells, rat insulinoma INS-1 cells, and mouse insulinoma
MIN-6 cells—all produced a smaller peptide with an apparent
molecular mass of 3 kDa that corresponds to ghrelin
(Figure 2B, lanes 2–7). Two nonendocrine cell lines—human
kidney HEK293 cells and Chinese hamster ovary (CHO-7)
cells—failed to produce mature ghrelin (lanes 8–11).
To confirm that the mature ghrelin band resulted from cleav-
age at arginine-28 of pro-ghrelin, we prepared cDNAs encoding
mutant forms of prepro-ghrelin with amino acid substitutions at
or near arginine-28. The cDNAs were transfected into INS-1
cells, and mature ghrelin was identified by SDS-PAGE and im-
munoblotting (Figure 2C). Replacement of arginine-28with either
lysine or leucine abolished cleavage (lanes 5 and 6), whereas re-
placement of residue 26 or 27 with an arginine reduced cleavage
but did not abolish it (Figure 2C, lanes 3 and 4).
To further confirm the sites of cleavage that generate ghrelin,
we prepared a cDNA encoding prepro-ghrelin with a Flag-tag
at the C terminus. We introduced this cDNA into INS-1 cells
and isolated the Flag-tagged peptides by adherence to an immu-
noaffinity gel. SDS-PAGE was used to separate the Flag-tagged
pro-ghrelin and the Flag-tagged C-terminal peptide that was
generated after cleavage at arginine-28 of ghrelin. The separated
peptides were then transferred to PVDF membranes and
processed for Edman degradation (Figure 2D). The N-terminal
sequence of pro-ghrelin was GSSFL, which is consistent with
cleavage of the signal sequence at the position indicated in
Figure 2A. The N-terminal sequence of the smaller fragment,
ALEG, is consistent with cleavage after arginine-28 of ghrelin.
Considered together, the data of Figures 2C and 2D indicate
that the INS-1 cells process prepro-ghrelin at the correct sites
to produce authentic mature ghrelin.Expression Cloning of Ghrelin O-Acyltransferase
Wenext developeda reverse-phasechromatographic procedure
toseparateoctanoylatedghrelin fromdesacyl-ghrelin (Figure2E).
For use as standards, we purchased synthetic octanoylated and
desacyl-ghrelin (see Experimental Procedures). The peptides
were applied to a C18 reverse-phase cartridge and eluted with
a step-gradient of 20%, 40%, and 80%-CH3CN in 0.1% TFA.
The eluted peptides were subjected to SDS-PAGE and immuno-
blotted with anti-ghrelin. As shown in the upper panel of Fig-
ure 2E, desacyl-ghrelin was eluted in the 20%-CH3CN fraction,(C) Alignment of amino acid sequences of GOAT orthologs in eight vertebrate species. Amino acid residues conserved in 50% or more of the sequences are
shaded. The putative catalytic asparagine and histidine residues are denoted by asterisks (*).Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc. 389
and octanoyl ghrelin was eluted in the 40%-CH3CN fraction. To
determine whether any of the endocrine cell lines could produce
octanoylated ghrelin, we transfected the cells with a cDNA
encoding prepro-ghrelin and subjected the extracted peptides
to reverse-phase chromatography. All of the ghrelin peptides
were eluted in the 20%-CH3CN fraction, indicating that none of
them was octanoylated (lower panel of Figure 2E).
Figure 3 shows a series of experiments designed to determine
whether any of 16MBOATs were capable of producing octanoy-
lated ghrelin when expressed with prepro-ghrelin in INS-1 cells.
We first prepared cDNAs encoding each of the MBOATs with
a C-terminal Flag-tag. When transfected into INS-1 cells, all of
these cDNAs produced MBOAT protein that could be detected
by SDS-PAGE and immunoblotting with anti-Flag (Figure 3A).
These cDNAs were then transfected into INS-1 cells together
with a cDNA encoding prepro-ghrelin. The ghrelin peptides
were extracted and subjected to reverse-phase chromatogra-390 Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc.phy. GOAT was the only MBOAT that produced acylated ghrelin,
which was detected as a 3-kDa band that emerged in the 40%-
CH3CN fraction (Figure 3B). To confirm the acylating activity of
GOAT, we repeated the cotransfection experiment (Figure 3C).
When the prepro-ghrelin cDNA was transfected together with
a control cDNA (pcDNA3.1), ghrelin emerged in the 20%-
CH3CN fraction, indicating a lack of acylation. We noted that
pro-ghrelin emerged in the 40% and 80%-CH3CN fractions
even though it was presumably not acylated. We attribute this
to the known tendency of longer peptides to adhere strongly to
reverse-phase resins even without acylation. When the GOAT
cDNA was transfected, approximately half of the ghrelin
emerged in the 40%-CH3CN fraction, indicating acylation. The
elution pattern of pro-ghrelin was the same as in the control cells
transfected with pcDNA3.1.
The activity of GOAT was not restricted to INS-1 cells. As
shown in Figure 3D, expression of GOAT led to acylation ofFigure 2. Processing of Prepro-Ghrelin in
Cultured Cells
(A) Amino acid sequence of mouse prepro-ghrelin.
As it enters the ER, prepro-ghrelin is processed
to pro-ghrelin by cleavage between alanine and
glycine, which removes the signal sequence.
Pro-ghrelin is further processed to ghrelin by pro-
hormone convertase 1/3, which cleaves between
arginine and alanine (Zhu et al., 2006). Asterisk (*)
denotes serine-3 of ghrelin, which is octanoylated.
(B) Processing of mouse pro-ghrelin (pro-Gh) in
different cell lines. The indicated cells were set
up for experiments on day 0 as described in Ex-
perimental Procedures. On day 2, one dish of
each cell line was transfected with 5 mg of mouse
prepro-ghrelin cDNA, and a second dish was sub-
jected to mock transfection with pcDNA3.1. On
day 4, cells were harvested, and peptideswere ex-
tracted for SDS-PAGE and immunoblot analysis
with rabbit anti-ghrelin antibody. Lane 1 contains
synthetic octanoyl-ghrelin.
(C) Effect of cleavage-site mutations on the pro-
cessing of pro-ghrelin. INS-1 cells were set up as
described in (B) and transfected on day 2 with
6 mg of a cDNA encoding the indicated wild-type
or mutant versions of prepro-ghrelin. On day 4,
cells were harvested for SDS-PAGE and immuno-
blot as in (B).
(D) N-terminal sequencing of pro-ghrelin and
C-terminal peptide containing a C-terminal Flag-
tag. On day 0, 30 dishes of INS-1 cells were set
up for experiments. On day 2, the cells were trans-
fected with 5 mg of a cDNA encoding mouse pre-
pro-ghrelin with a C-terminal Flag-tag. On day 4,
the cells were solubilized in Triton X-100, and
a small aliquot of the resulting 100,000 3 g supernatant (1% of sample) was subjected to SDS-PAGE and immunoblotted with anti-Flag M2 monoclonal anti-
body (left panel, lanes 1–3) as described in Experimental Procedures. The remainder of the 100,0003 g supernatant was treated with anti-Flag affinity gel, after
which the eluted proteins were subjected to SDS-PAGE and transferred to a PVDF membrane. The separated peptides corresponding to pro-ghrelin and its
C-terminal peptide (identified by amido black staining) were then processed for Edman degradation as described in Experimental Procedures. The N-terminal
sequences are shown in the right panel.
(E) Production of desacyl-ghrelin but not octanoylated ghrelin in three endocrine cell lines. The indicated cells were set up for experiments on day 0. On day 2,
each dish of cells was cotransfected with 3 mg mouse prepro-ghrelin cDNA and 2 mg pcDNA3.1 mock vector. On day 3, each dish of cells received a direct ad-
dition of 100 mMoctanoate-albumin (final concentration). On day 4, four dishes of cells from each cell line were harvested and pooled, and the extracted peptides
were fractionated by reverse-phase chromatography as described in Experimental Procedures. The three eluted fractions (25% of each sample) were subjected
to SDS-PAGE and immunoblot analysis with rabbit anti-ghrelin antibody. The band corresponding in molecular mass to ghrelin is shown. Synthetic desacyl-
ghrelin and octanoyl-ghrelin were studied as standards.
ghrelin in each of the three endocrine cell lines that were capable
of processing pro-ghrelin to ghrelin. Figure 3E confirms that the
GOAT protein was expressed in the three transfected cell lines.
Molecular Characterization of the Octanoylating
Activity of GOAT
To confirm that ghrelin was acylated by GOAT, we tested the
lability of the modification to hydroxylamine treatment, which is
known to release ester-bound fatty acids from proteins at alka-
line pH (Bizzozero, 1995). As shown in the upper panel of
Figure 4A, when synthetic octanoylated ghrelin was treated
with 1 M hydroxylamine (pH 8.0), the peptide no longer eluted
from the reverse-phase cartridge in the 40%-CH3CN fraction.
Treatment with 1 M Tris-chloride (pH 8.0) had no such effect.
The lower panel of Figure 4A shows the results of hydroxylamine
treatment of peptide extracts obtained from INS-1 cells trans-
fected with cDNAs encoding prepro-ghrelin and GOAT. When
treated with 1M Tris-chloride, ghrelin eluted from the reverse-
phase cartridge in the 40%-CH3CN fraction, but when treated
with 1 M hydroxylamine it reverted to the 20%-CH3CN fraction,
indicating that it had been deacylated.
Octanoylation of ghrelin in vivo is known to occur at serine-3 of
the peptide. Mutation of serine-3 to alanine prevented acylation
by GOAT, indicating that GOAT acylates the physiologic serine
residue (Figure 4B). Replacement of serine-3 with threonine pre-
served acylation, a finding consistent with the observation thatthis position is occupied by an octanoylated threonine in bullfrog
ghrelin (Kojima and Kangawa, 2005). Substitution of alanine for
other serines in ghrelin (residues 2, 6, and 18) did not affect
acylation (Figure 4B).
As shown in Figure 1, the predicted catalytic residues in
mouse GOAT are asparagine-307 and histidine-338. Figure 5A
shows that both of these residues are required in order for
GOAT to modify ghrelin. Substitution of either of these residues
with alanine abolished the ability of GOAT to acylate ghrelin. An-
other mutation (cysteine-181 to alanine) had no effect. Figure 5B
shows that all of the GOAT cDNAs were expressed at similar
levels in the transfected cells.
To confirm that GOAT modifies ghrelin with octanoate, we
transfected INS-1 cells with cDNAs encoding prepro-ghrelin,
and wild-type or mutant version of GOAT (Figure 6). The cells
were incubated with [3H]octanoate, and the extracted peptides
were subjected to reverse-phase chromatography. Each 40%-
CH3CN fraction was subjected in duplicate to SDS-PAGE, after
which the radiolabeled peptides were transferred to duplicate
PVDF membranes. One membrane was subjected to immuno-
blot analysis with anti-ghrelin (Figure 6A), demonstrating that
pro-ghrelin was present in all lanes (1–6) while acylated ghrelin
was detected only in lane 2. The other membrane was subjected
to autoradiography to visualize the labeled proteins (Figure 6B).
For quantification, each lane of the membrane was cut into
9 slices, which were then subjected to scintillation countingFigure 3. Identification of GOAT by Expres-
sion Testing of 16 MBOAT cDNAs
INS-1 cells were set up for experiments on day 0.
(A) Expression of 16 MBOATs by cDNA transfec-
tion in INS-1 cells. On day 2, cells were transfected
with 5 mg of cDNA encoding the indicated mouse
MBOAT with a C-terminal Flag-tag. On day 4, cells
from two dishes were harvested and pooled, and
the 20,000 3 g membrane fraction (representing
20% of one dish of cells; membranes prepared
as described by Nohturfft, et al. [2000]) was sub-
jected to 10% SDS-PAGE and immunoblot analy-
sis with anti-Flag M2 monoclonal antibody. Aster-
isk (*) denotes an irrelevant cross-reacting band
present in the membrane fraction of INS-1 cells.
(B) GOAT is the only MBOAT that acylates ghrelin.
On day 2, cells were cotransfected with 3 mg of
a cDNA encoding mouse prepro-ghrelin and 2 mg
of a cDNA encoding the indicated MBOAT. On
day 3, each dish received a direct addition of
100 mM octanoate-albumin (final concentration).
On day 4, four dishes of cells from each transfec-
tion were harvested and pooled, after which pep-
tide extracts were processed for reverse-phase
chromatography as described in Figure 2E.
(C) Acylation of ghrelin by GOAT. On day 2, cells
were cotransfected with 5 mg of a cDNA encoding
mouse prepro-ghrelin and 0.2 mg of a cDNA
encoding mock vector pcDNA3.1 or GOAT. Cells
were then processed exactly as described in (B)
except the bands corresponding to both pro-
ghrelin and ghrelin are shown.
(D) GOAT acylates ghrelin when expressed in three endocrine cell lines. The indicated cells were cultured, transfected, and processed as described in (C).
(E) Expression of GOAT by cDNA transfection in three endocrine cell lines. The indicated cells were cultured, transfected, and processed as described in (A)
except that on day 2 the cells were transfected with 6 mg of a cDNA encoding GOAT with a C-terminal HA-tag, and on day 4 the membrane fraction (representing
40% of one dish of cells) was immunoblotted with 0.5 mg/ml anti-HA monoclonal antibody.Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc. 391
(Figure 6C). When the cells were transfected with the GOAT
cDNA, labeled peptides were observed in the position of pro-
ghrelin (dark upper band in lane 2 of Figure 6B) and ghrelin
(diffuse lower band in lane 2). As expected, no radioactivity
was incorporated into the S3A mutant of ghrelin (lane 3). Lane
4 shows the result when prepro-ghrelin contained leucine in
place of arginine at the residue corresponding to position 28 of
ghrelin. This substitution prevents the cleavage of pro-ghrelin
to ghrelin (see Figure 1C). In this case, we observed radiolabeling
of the pro-ghrelin band, but there was no ghrelin band (lane 4).
We observed no labeled band when the cells were transfected
with a cDNA encoding a catalytically inactive mutant of GOAT
(H338A) (lane 5). As a further control, we found that transfection
of a cDNA encoding another MBOAT (MBOAT1-a) failed to
produce a radiolabeled band (lane 6).
To verify that the cells had incorporated [3H]octanoate without
changing its length, we removed the labeled fatty acid from the
protein by methanolysis and subjected the methyl ester to thin-
layer chromatography (TLC) in a system that separates fatty
acidmethyl esters according tochain length.Scintillationcounting
of the TLC plate confirmed that thematerial attached to pro-ghre-
lin and ghrelin was the eight-carbon [3H]octanoate (Figure 6D).
Figure 4. Modification of Ghrelin by GOAT through O-linked Acyla-
tion at Serine-3
INS-1 cells were set up for experiments on day 0.
(A) Hydroxylamine treatment. On day 2, cells were cotransfected with 5 mg of
a cDNA encodingmouse prepro-ghrelin and 0.2 mg of a cDNA encodingGOAT.
On day 4, each dish of cells received a direct addition of 50 mM octanoate-
albumin (final concentration). On day 5, 10 dishes of cells were harvested
and pooled, after which peptide extracts were processed for reverse-phase
chromatography. The 40%-CH3CN fraction and a synthetic octanoyl ghrelin
standard were subjected to treatment with either 1 M Tris-chloride (pH 8.0)
or 1 M NH2OH (pH 8.0) (Bizzozero, 1995), followed by reverse-phase chroma-
tography, SDS-PAGE, and immunoblot with rabbit anti-ghrelin antibody.
(B) Mutational analysis. On day 2, each dish of cells was cotransfected with
1 mg of a cDNA encoding GOAT cDNA and 4 mg of a cDNA encoding the indi-
cated wild-type or mutant versions of mouse prepro-ghrelin. On day 3, each
dish received 50 mM octanoate-albumin (final concentration). On day 4, four
dishes of cells were processed for reverse-phase chromatography as
described in Figure 2E.392 Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc.Relative Distribution of GOAT and Prepro-Ghrelin
mRNAs in Mouse Tissues
Finally, we used semiquantitative PCR to compare the levels of
GOAT and prepro-ghrelin mRNAs in various tissues of themouse
(Figure 7). As previously reported (Kojima et al., 1999), prepro-
ghrelin mRNA was expressed most highly in the stomach fol-
lowed by the intestine. There was very little expression in other
tissues. Likewise, GOATmRNAwas highest in stomach, and de-
tectable in the small intestine and colon. Among other organs,
only the testis had detectable amounts of GOATmRNA. In stom-
ach, we noted that the amount of GOAT mRNA appeared to be
much lower than the amount of prepro-ghrelin mRNA. Even after
35 cycles of PCR, the intensity of the amplified GOAT product
was less than that observed with prepro-ghrelin after only 30
cycles. This relative difference of200-fold was confirmed in ex-
periments using quantitative real-time RT-PCR (data not shown).
DISCUSSION
In the current paper, we identify the enzyme that attaches octa-
noate to ghrelin, a modification that is essential for the biologic
activity of the peptide. The enzyme, which we name GOAT, be-
longs to the MBOAT family of acyltransferases that attach fatty
acids to lipids and proteins (Hofmann, 2000). All of the previously
studied enzymes in this family transfer long-chain fatty acids of
at least 16 carbons. GOAT is unique because it is the first family
member that transfers a medium-chain fatty acid such as octa-
noate. Inasmuch as ghrelin is the only known octanoylated
protein in animals, it seems likely that ghrelin is the sole substrate
for GOAT.
Figure 5. Identification of Residues in GOAT Required for Catalysis
INS-1 cells were set up for experiments on day 0.
(A) On day 2, each dish of cells was cotransfected with 4 mg of a cDNA encod-
ingmouse prepro-ghrelin and 1 mg of a cDNA encoding the indicated wild-type
or mutant versions of GOAT. On day 3, cells were treated with 50 mM octa-
noate-albumin (final concentration). On day 4, four dishes of cells were
processed for reverse-phase chromatography as described in Figure 2E.
(B) On day 2, each dish of cells was transfected with 6 mg of a cDNA encoding
the indicated wild-type or mutant versions of GOAT with a C-terminal HA-tag.
On day 4, the membrane fraction (representing 40% of one dish of cells) was
processed for immunoblot analysis with anti-HA monoclonal antibody as
described in Figure 3E.
The only other MBOATs that are known to acylate proteins are
Hedgehog acyltransferase (HHAT) and Porcupine, both of which
transfer long-chain fatty acids. HHAT palmitoylates a cysteine
residue in Sonic Hedgehog (Chen et al., 2004), whereas Porcu-
pine is believed to acylate both a cysteine and a serine in Wnt
(Willert et al., 2003; Takada et al., 2006). Neither HHAT nor Por-
cupine transfers octanoate to ghrelin (Figure 3B). It is noteworthy
that GOAT, Porcupine, and HHAT acylate proteins that reside in
luminal compartments in the secretory pathway. It will be inter-
Figure 7. Expression of GOAT mRNA in Different Mouse Tissues
GOAT and prepro-ghrelin mRNAs were detected by one-step RT-PCR from
total RNA of 14 mouse tissues as described in Experimental Procedures.
RT-PCR of b-actin mRNA was used as an RNA quality control.esting to determine whether some of the unassigned MBOATs
act on luminal protein substrates.
The [3H]octanoate-labeling data of Figure 6 indicate that pro-
ghrelin is octanoylated before it is transported to the Golgi where
it is cleaved by prohormone convertase 1/3 (PC 1/3) to form ma-
ture ghrelin. This observation is consistent with the finding that
pro-ghrelin isolated from PC 1/3 knockout mice was acylated
(Zhu et al., 2006). These data suggest that GOAT is located in
the endoplasmic reticulum (ER). The presumed donor for octa-
noylation is octanoyl-CoA, but how octanoyl-CoA gets into the
ER lumen is unclear. One function of GOAT may be to transfer
the octanoyl-CoA from the cytosolic side of the ER membrane
to the luminal side. The hydrophobic nature of GOAT may assist
in this translocation. GOAT appears to be specific for medium
chain fatty acids like octanoate. In data not shown, when trans-
fected INS-1 cells were radiolabeled with [3H]palmitate exactly
as described for [3H]octanoate in Figure 6, we did not detect
any [3H]palmitate incorporation into ghrelin.
Ghrelin is the N-terminal fragment that is generated by cleav-
age of pro-ghrelin. The C-terminal fragment has been called
‘‘obestatin.’’ A recent claim that obestatin binds to a G protein
coupled receptor and acts as a ghrelin antagonist (Zhang
et al., 2005) has been refuted (Chartrel et al., 2007; Gourcerol
et al., 2007; Nogueiras et al., 2007). At present, there is no clear
evidence for a function for the C-terminal peptide. Whether the
C-terminal peptide of pro-ghrelin plays any role in octanoylationFigure 6. GOAT-Mediated Incorporation of
[3H]Octanoate into Pro-Ghrelin and Ghrelin
(A–C) Two dishes of INS-1 cells were set up for ex-
periments on day 0. On day 2, cells were cotrans-
fectedwith 5 mg of prepro-ghrelin (wild-type ormu-
tant) and 0.2 mg of either GOAT (wild-type or
mutant) or MBOAT1-a as indicated in Panels 1–6
in (C). On day 3, cells were switched to medium B
containing 10% delipidated FCS rather than FCS.
On day 4, cells were radiolabeled by incubation in
8 ml medium B containing no serum and supple-
mented with 1% (v/v) Insulin, Transferrin & Sele-
nium Solution (ITS; Mediatech, Inc.), 0.1 mg/ml
BSA, and 0.1 mM [3H]octanoate (132 dpm/fmol).
After incubation for 24 hr at 37C, cells were
harvested, pooled, and fractionated by reverse-
phase chromatography. Each 40%-CH3CN frac-
tion (representing two dishes of cells) was divided
into two equal aliquots, each of which was sub-
jected to 16% Tricine SDS-PAGE. After electro-
phoresis, the separated proteins in each gel were
transferred to a PVDF membrane, after which
onemembranewas processed for immunoblotting
and the other for 3H-autoradiography. (A) Immuno-
blot analysis with rabbit anti-ghrelin antibody.
(B) 3H-Autoradiography. After autoradiography,
each lane was cut into nine consecutive slices
(numbered 1–9), followed by liquid scintillation
counting as described in Experimental Proce-
dures. (C) Quantification of 3H-radioactivity. The
amount of 3H-radioactivity contained in each of
the nine slices is plotted.
(D) Identification of 3H-labeled fatty acid on pro-ghrelin and ghrelin. Two dishes of INS-1 cells were set up, cotransfected with 5 mg mouse prepro-ghrelin cDNA
and 0.2 mg GOAT cDNA, and radiolabeled with [3H]octanoate as above. The identity of the 3H-fatty acid covalently attached to pro-ghrelin and ghrelin was iden-
tified by fatty acidmethyl ester (FAME) analysis as described in Experimental Procedures. The positions ofmigration of the FAMEstandards on reverse-phase TLC
(C6:0 to C16:0 methyl esters) are shown at the top.Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc. 393
of ghrelin is not known. This question should be answerable now
that GOAT has been identified.
The relative tissue distribution of GOATmRNAmatches that of
ghrelin (Figure 7). It is highest in stomach. In the intestine, the two
mRNAs decline with increasing distance from the pylorus. Semi-
quantitative PCR experiments suggest that GOAT mRNA is
much less abundant than ghrelin mRNA, which would be consis-
tent with the relationship between an enzyme and its substrate.
In the stomach, ghrelin has been localized to a minor population
of specialized cells that have been called ‘‘ghrelin cells.’’ (Date
et al., 2000; Kojima and Kangawa, 2005). It will be important to
determine whether GOAT is also restricted to these cells.
In the current experiments with INS-1 cells, we supplied octa-
noate in the culture medium. In the stomach one source of octa-
noate is the diet (Nishi et al., 2005). Mammalian cells are not
known to synthesize medium-chain fatty acids, but a specialized
synthetic pathway for generating these fatty acids in ghrelin cells
cannot be ruled out.
A major unanswered question relates to the reason why ghre-
lin, among all other proteins, is the only one that is octanoylated.
This unique modification has been conserved in birds, reptiles,
amphibians, and fish (Kojima and Kangawa, 2005; Kaiya et al.,
2004). The octanoyl group is crucial for ghrelin’s ability to bind
to and activate its receptor, but is this the only reason for the
modification? Does octanoylation provide a mechanism to con-
trol ghrelin activity or tissue distribution? These questions should
be addressable now that GOAT has been identified.
The discovery of GOAT opens theway to a search for chemical
inhibitors that may be useful in controlling appetite. Peripheral
and central ghrelin administration is well documented to in-
crease food intake in rodents and humans, presumably through
actions in the hypothalamus (Cummings, 2006; Zigman and Elm-
quist, 2006). Available data suggest that a reduction in ghrelin or
its receptor can reduce food intake and partially ameliorate obe-
sity in fat-fedmice (Zorrilla et al., 2006; Zigman et al., 2005;Wort-
ley et al., 2005). Whether such a reduction would reduce weight
in humans is unknown, but development of a GOAT inhibitor
should allow testing of this hypothesis.
EXPERIMENTAL PROCEDURES
Materials and General Methods
Synthetic desacyl-ghrelin and octanoyl-ghrelin were obtained from AnaSpec
(San Jose, CA). Anti-Flag M2 monoclonal antibody, anti-Flag M2 Affinity Gel,
anti-HA monoclonal antibody, bovine serum albumin (essentially fatty-acid
free), all solvents, and other chemicals were obtained from Sigma unless other-
wise specified. Octanoic acid was bound to albumin at a final concentration of
10mM fatty acid and 10% (w/v) bovine serumalbumin in 0.15M sodiumchloride
as previously described (Hannah et al., 2001). [3H-2,20,3,30]octanoate (60 Ci/
mmol) was obtained from American Radiolabeled Chemicals. Delipidated fetal
calf serum (FCS)waspreparedbysolventextractionwithn-butanoland isopropyl
ether aspreviously described (Hannah et al., 2001). Standardmethods ofmolec-
ular biology (SambrookandRussell, 2001)wereusedunlessotherwise specified.
Bioinformatic Identification and cDNA Cloning of Mouse MBOATs
Sixteen members of the MBOAT family were identified in the mouse genome,
using reported MBOAT sequences (Hofmann, 2000) for queries and PSI-
BLAST searches (E-value cutoff 0.005, default parameters) (Altschul et al.,
1997) against the nonredundant protein sequence database.
Full-length cDNAs for 15 of the 16 MBOATs were cloned by RT-PCR of total
RNA. RNA was isolated from the stomach of C57BL/6J mice that had been394 Cell 132, 387–396, February 8, 2008 ª2008 Elsevier Inc.either fasted for 16 hr or fed a chow diet ad libitum. Both sets of RNA were
pooled together before RT-PCR. The cloned sequences with or without addi-
tion of sequences encoding a C-terminal Flag-tag (DYKDDDDK) or HA-tag
(YPYDVPDYA) were inserted into pcDNA3 or pcDNA3.1 vectors (Invitrogen)
driven by the cytomegalovirus (CMV) promoter-enhancer. Primers for RT-
PCR were designed according to the coding sequences available in the Na-
tional Center for Biotechnology Information (NCBI) database (Table S1 avail-
able online). For each MBOAT without isoforms, 10–20 cDNA clones were
sequenced in their entirety; for the three MBOATs with multiple isoforms
(MBOAT1, MBOAT2, and porcupine), 60 to 80 cDNA clones were sequenced.
For one of the 16MBOATs, we initially failed to clone a full-length cDNA. This
MBOAT was designated in the NCBI database (May 2007) as ‘‘similar to
O-acyltransferase (membrane bound) domain containing 1’’ (XM_134120).
Efforts to clone its cDNA failed because the NCBI annotation at the 50 end
was incorrect. As a result, the 50 primers failed to prime PCR amplification.
We therefore synthesized an artificial cDNA according to the sequence of
XM_134120. After obtaining four segments of DNA corresponding to nucleo-
tides 1-391, 398-885, 907-1254, and 1261-1581 of XM_134120 (synthesized
by Integrated DNA Technologies, Coralville, IA), we pieced them together by
fusion-PCR (Karreman, 1998). On June 20, 2007, the incorrect NCBI annota-
tion of XM_134120 was replaced by two new annotations that were renamed
MBOAT4, XM_001476434 and XM_001472220. These two versions of
MBOAT4 differed from each other by 376 nucleotides at the 50-end, and
they differed from XM_134120 at the 50-end in the following ways:
XM_001476434 was 211 bp shorter than XM_134120 and XM_001472220
was 165 bp longer than XM_134120. To determine the correct 50-end of the
MBOAT4 mRNA, we carried out 50 rapid amplification of cDNA ends
(50-RACE) using total RNA from mouse stomach, 30 nested primers designed
according to the sequence of the longer putative MBOAT4 transcript
XM_001472220, and the FirstChoice RLM-RACE Kit (Ambion). The results
showed that the correct annotation was XM_001476434. The current NCBI
database (December 1, 2007) contains partial DNA sequence information on
11 ESTs corresponding to XM_001476434. Of the 11 ESTs, only one of them
(IMAGE 5655946) extends to the 50-end. This sequence corresponds to the
cDNA that we subsequently showed to encode ghrelin O-acyltransferase
(GOAT).
A full-length cDNA for mouse GOAT was generated by RT-PCR of total
stomach RNA as described above. The chimpanzee ortholog (XP_519692) of
mouseGOATwas identified by a ‘‘blastp’’ analysis of the nonredundant protein
database. Orthologs of GOAT in other species (Figure 1C) were found by clus-
tering identified genomic sequences with the SEALS command grouper (with
criterion –lscut = 0.6) (Walker and Koonin, 1997). In genomic DNA from several
species, the annotation of exons did not contain the N-terminus of the
sequence. In these cases we used the N-terminal amino acid sequence trans-
lated from mouse cDNA as a query, which allowed us to identify complete
GOAT ortholog amino acid sequences through the use of tblastn searches
(http://www.ncbi.nlm.nih.gov/BLAST/). The reference numbers for the corre-
sponding genomic DNA sequences were as follows: rat (NW_047474.1), hu-
man (NT_007995.14), bovine (NW_001494415.1), horse (NW_001799700.1),
chicken (NW_001471685.1), and zebrafish (NW_001513480.1). Alignments
were carried out by ClustalW.
Cell Culture and Transient Transfection
All cells were grown in monolayer at 37C in an atmosphere of 8.8% CO2.
Mouse AtT-20 cells (obtained from American Type Culture Collection) were
cultured in medium A (Dulbecco’s modified Eagle’s medium (4.5 g/L glucose)
supplemented with 2 mM glutamine, 10% (v/v) FCS, 100 U/ml penicillin, and
100 mg/ml streptomycin). Rat INS-1 cells (Asfari et al., 1992) and mouse
MIN-6 cells (Miyazaki et al., 1990) were obtained from Dr. Melanie Cobb (Uni-
versity of Texas Southwestern Medical Center). INS-1 cells were cultured in
medium B (RPMI 1640 medium supplemented with 10% FCS, 10 mM HEPES,
50 mM b-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml streptomycin).
MIN-6 cells were cultured in medium C (Dulbecco’s modified Eagle’s medium
(4.5 g/L glucose) supplemented with 10% FCS, 10 mM HEPES, 50 mM
b-mercaptoethanol, 100 U/ml penicillin, and 100 mg/ml streptomycin).
For transient transfections, AtT-20 cells were set up on day 0 at 13 106 per
100-mmdish; INS-1 cells andMIN-6 cells were set up at 1.53 106 per 100-mm
dish. On day 2, cells were transfected with plasmids using FuGENE HD Trans-
fection Reagent (Roche) at a ratio of FuGENE HD to plasmids of 3:1. On day 3
or 4, cells were subjected to various treatments as described in figure legends.
On day 4 or 5, cells were harvested for experiments. The total amount of trans-
fected DNA in each experiment was constant and adjusted to 5 or 6 mg per
100-mm dish by addition of pcDNA3.1 mock vector.
Generation of Anti-Ghrelin Antibody
DNA segments encoding mouse pro-ghrelin and ghrelin were cloned into
pGEX-4T1 (GE Healthcare) to generate glutathione S-transferase (GST)-fusion
proteins. For the GST-pro-ghrelin construct, the thrombin cleavage site within
the vector sequence (LVPRGS) between GST and pro-ghrelin was changed to
the Tobacco Etch Virus (TEV) protease site (ENLYFQG), and a His8-tag was
added to the C terminus of pro-ghrelin. GST-pro-ghrelin-His8 and GST-ghrelin
were expressed in E. coli and purified using glutathione-agarose beads. GST-
pro-ghrelin-His8 was cleaved by recombinant TEV protease (produced in
E.coli as a GST fusion protein) to release pro-ghrelin-His8, which was further
purified by nickel-affinity chromatography (QIAGEN). For immunization, each
rabbit was injected subcutaneously with 500 mg GST-ghrelin in incomplete
Freund’s adjuvant, followed by alternating booster injections of 250 mg GST-
ghrelin or 250 mg pro-ghrelin-His8, both given subcutaneously in incomplete
Freund’s adjuvant at two week intervals. The resulting rabbit anti-ghrelin anti-
serum recognized pro-ghrelin and ghrelin in both the desacylated and acylated
forms. The antiserum did not recognize the C-terminal peptide derived from
proghrelin cleavage.
Peptide Extraction from Cultured Cells
Peptides were extracted from cultured cells using the protocol described by
Kojima et al. (1999). After harvesting, the cell pellet was boiled in 1-2 ml of
H2O for 10min to inactivate proteases and then cooled on ice, after which ace-
tic acid and HCl were added directly to achieve final concentrations of 1 M and
20 mM, respectively. The cell lysate was further disrupted by passage through
a 22-gauge needle 10 times, followed by centrifugation at 20,000g for 10min at
4C. The resulting supernatant was concentrated under vacuum to 20% of
the original volume, subjected to 67% (v/v) acetone precipitation, and centri-
fuged at 20,000g for 10 min at 4C to remove the precipitate. The supernatant
was evaporated under vacuum, and the residue was solubilized for SDS-PAGE
and immunoblot analysis or reverse-phase chromatography followed by SDS-
PAGE and immunoblot analysis as described below.
Immunoblot Analysis of Pro-Ghrelin and Ghrelin
The pellet containing the extracted peptides was dissolved in SDS-PAGE
loading buffer (0.1M Tris-chloride at pH 6.8, 5% (w/v) SDS, 0.1Mdithiothreitol,
and 5% (v/v) glycerol), subjected to 16% Tricine SDS-PAGE, and then trans-
ferred to Immobilon-P PVDF membranes (Millipore) for immunoblot analysis.
To prevent the diffusion of ghrelin during the blotting procedure, we washed
each membrane three times with Phosphate-Buffered Saline (PBS) containing
0.05% Tween-20 (Sigma), after which the membrane was fixed at room tem-
perature for 15 min in 50 mMHEPES-NaOH (pH 7.4) containing 2.5% (v/v) glu-
taraldehyde. The membrane was washed three times with the PBS/Tween-20
solution and then immunoblotted with either a 1:1000 dilution of anti-ghrelin
antiserum or 0.5 mg/ml of anti-FlagM2monoclonal antibody. Bound antibodies
were visualized by chemiluminescence (SuperSignal West Pico Developing
Kit; Pierce) using a 1:10,000 dilution of either donkey anti-rabbit IgG or donkey
anti-mouse IgG conjugated to horseradish peroxidase (Jackson ImmunoRe-
search). All membranes were exposed to Phoenix Blue X-ray film for 5 s to
2 min at room temperature.
Separation of Desacyl-Ghrelin and Acyl-Ghrelin
by Reverse-Phase Chromatography
The residue after evaporation of the acetone was dissolved in 3 ml of 2% (v/v)
CH3CN in 0.1% (v/v) trifluoroacetic acid (TFA) and loaded onto a 360 mg Sep-
PakC18-cartridge (Waters). The cartridge waswashedwith 3ml of 2%CH3CN
in 0.1% TFA and eluted with a step-gradient consisting of 6 ml of solution con-
taining 20%, 40%, and 80%-CH3CN in 0.1% TFA. The first 3 ml of each 6 ml
elution were collected and evaporated under vacuum, and the residue wasdissolved in 80 ml of SDS-PAGE loading buffer, and aliquots of 20 ml were sub-
jected to SDS-PAGE and immunoblot analysis as described above.
[3H]Octanoate Autoradiography and Identification of [3H]Fatty Acid
[3H]Octanoate-labeled INS-1 cells were processed as described in the legend
to Figure 6 and then subjected to autoradiography with a Kodak Transcreen LE
Intensifying Screen and Biomax MS Film at 80C for 5 days. Radioactivity in
the PVDF membrane was quantified by cutting each lane into 9 consecutive
pieces from top to bottom, followed by liquid scintillation counting in 10 ml
of counting cocktail (3a70B, Research Products International Corp.).
To confirm the identity of the 3H-labeled fatty acid linked to pro-ghrelin and
ghrelin, fatty acid methyl ester (FAME) analysis was carried out. Two dishes of
transfected cells were radiolabeled with [3H]octanoate. After reverse-phase
chromatography, proteins in the 40%-CH3CN fraction were subjected to
SDS-PAGE and transferred to a PVDF membrane. The pieces of membrane
containing 3H-labeled pro-ghrelin and ghrelin were cut out, pooled together,
and treated with 0.5 ml of 0.1 M KOH in 100% methanol at room temperature
for 2 hr to form FAME. After acidifying the sample with 0.5 ml of 1.0 M HCl, the
aqueous phase was extracted twice with 0.1 ml hexane. An aliquot of the
pooled organic phase (50 ml) was mixed with 50 mg of each FAME standard
(methyl hexanoate, methyl octanoate, methyl decanoate, methyl dodeca-
noate, methyl myristate, and methyl palmitate) and loaded onto a C18 re-
verse-phase thin-layer chromatography (TLC) plate (150 mm, 10x20 cm, Anal-
tech). The TLC plate was developed in a solvent system of acetone/methanol/
water (80:20:10, v/v/v), and FAME standards were revealed by iodine vapor
counter-staining. The lane of TLC was divided into strips numbered 1 to 14
from the origin to the front, with strips 6 to 11 containing FAME standards.
The resin on each strip was then scraped off and subjected to liquid scintilla-
tion counting as described above.
GOAT mRNA Expression in Mouse Tissues
Six-month old male C57BL/6J mice were fed a chow diet ad libitum prior to
study. At the end of the dark phase, mice were anesthetized and exsangui-
nated. Various tissues were collected, snap-frozen in liquid nitrogen, and
stored at 80C. The stomach, small intestine, and colon were flushed with
cold PBS, after which the small intestine was divided into three equal lengths,
designated duodenum (proximal), jejunum (medial), and ileum (distal). Each
flushed segment of the gastrointestinal tract was cut open with a small scis-
sors, and the mucosa was carefully scraped off and placed in a tube for
RNA preparation. Total RNA was prepared from mouse tissues using an
RNA STAT-60 kit from Tel-Test Inc. (Friendswood, Texas, USA). Equal
amounts of RNA from four mice were pooled, treated with DNase I (TURBO
DNA-free, Ambion), and analyzed for mRNA expression of GOAT, prepro-
ghrelin, and b-actin using the TITANIUM One-Step RT-PCR Kit (Clontech).
Each reaction contained 1 mg of DNase I-treated total RNA isolated from differ-
ent mouse tissues and primers shown in Table S2. The cycling parameters
were set as 94C, 30 s; 60C, 30 s; and 68C, 30 s. Number of cycles for
GOAT, prepro-ghrelin, and b-action was 35, 30, and 25, respectively. Aliquots
(20 ml) of the 50-ml RT-PCR samples were loaded onto 1.5% agarose gel. All
animal experiments were performed with the approval of the Institutional
Animal Care and Research Advisory Committee at the University of Texas
Southwestern Medical Center at Dallas.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and two
tables and can be found with this article online at http://www.cell.com/cgi/
content/full/132/3/387/DC1/.
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